• Partial BACE Inhibition and Synaptic Transmission

  2026-09-04

  Satir et al. used optical electrophysiology in cultured rat cortical neurons to test whether moderate BACE inhibition can lower amyloid beta secretion without impairing neuronal communication. The study found that amyloid beta reduction below 50% preserved synaptic transmission across three inhibitors, whereas stronger inhibition reduced both measures, supporting exposure strategies that separate target engagement from synaptic dysfunction.

• 2D and 3D Radiosensitizer Screening in Lung Cancer

  2026-09-04

  The 2025 Acta Oncologica study systematically compared DNA-PKcs, ATR, PARP, and IAP pathway inhibitors in conventional 2D and extracellular-matrix-supported 3D lung cancer models. Its findings show that 2D assays often identify the same radiosensitizers as 3D systems, while 3D cultures add information about matrix-dependent and cell-line-specific responses that can improve preclinical prioritization.

• Canagliflozin in Renal Mitochondrial Research

  2026-09-03

  Canagliflozin enables researchers to connect renal glucose reabsorption inhibition with proximal-tubule mitochondrial structure, bioenergetics, and kidney injury markers. This workflow-focused guide shows how to translate SGLT2 inhibition into reproducible cell and mouse assays while controlling for solvent, sex, glycemia, and respirometry variables.

• BIRB 796 (Doramapimod) Assay Guide

  2026-09-03

  A scenario-based guide to using BIRB 796 (Doramapimod), SKU A5639, in cell viability, apoptosis, cytokine, and p38 MAPK experiments. It connects biochemical selectivity with practical stock preparation, assay controls, interpretation limits, and evidence-aware vendor selection.

• Adipose-Neural Signaling in Cardiac Arrhythmia

  2026-09-02

  Fan et al. establish a stem cell-based coculture model showing how epicardial adipose tissue can communicate with sympathetic neurons and cardiomyocytes through a leptin–NPY/Y1R pathway. The findings connect adipose-derived signaling with NCX and CaMKII activity, while patient data support increased epicardial fat and leptin/NPY levels as clinically relevant correlates of atrial fibrillation.

• Deferoxamine Mesylate: Iron Redox Assay Guide

  2026-09-02

  Deferoxamine mesylate gives researchers a practical way to manipulate labile iron, oxidative injury, ferroptosis susceptibility, and hypoxia signaling in controlled models. This workflow-focused guide covers preparation, HIF-1α stabilization, tumor and tissue assays, experimental controls, and troubleshooting limits.

• Dextromethorphan hydrobromide Workflows

  2026-09-01

  Build more reproducible NMDA and excitotoxicity assays with a controlled workflow for Dextromethorphan hydrobromide. The guide connects electrophysiology, cell-based neuroprotection, and cerebral ischemia model design while showing how the reference study supports stronger assay validation—not a new claim about the compound’s target.

• VX-745 and the Logic of p38α Signal Control

  2026-09-01

  VX-745 is a selective p38α MAPK inhibitor for dissecting kinase activity, inflammatory cytokine output, and phosphorylation-state dynamics. This guide connects product biology with a recent structural study to improve assay interpretation across inflammation, multiple myeloma, and aging research.

• Mifepristone (RU486) Applied Research Workflows

  2026-08-31

  Mifepristone (RU486) gives researchers a titratable way to interrogate progesterone receptor signaling across cancer, reproductive biology, and cell-based mechanism studies. This workflow emphasizes solvent control, receptor attribution, orthogonal endpoints, and careful translation of tissue-specific nuclear-receptor findings.

• Berberine Hydrochloride: Applied Research Workflow

  2026-08-31

  Build reproducible Berberine hydrochloride experiments across lipid metabolism, hepatoma LDLR assays, cancer biology, and inflammation models. This workflow emphasizes solvent control, pathway-resolved readouts, and a cautious translation of oxidized self-DNA findings in acute kidney injury research.

• ICG001: Wnt/β-Catenin Pathway Inhibitor

  2026-08-30

  ICG001 is a selective Wnt/β-catenin pathway inhibitor that disrupts the CBP/β-catenin transcriptional complex while sparing p300. Its defined mechanism supports Wnt signaling modulation in colon cancer, stem-cell, and fibrosis models, but the compound has not been established as a treatment for biliary-atresia liver fibrosis.

• Protease Inhibitor Cocktail for Dynamic Biology

  2026-08-29

  Learn how a Protease Inhibitor Cocktail protects degradation-sensitive studies of HSP90, METTL3, and MYC. This guide translates mechanistic cancer biology into practical sample-preservation and assay-design decisions.

• Tunable Human Intestinal Organoids: Study Insights

  2026-08-28

  A 2025 Nature Communications study establishes a human small intestinal organoid system that maintains strong proliferation while expanding cellular diversity under a single culture condition. Its central innovation is to increase stem-cell competence first, then use reversible or directional pathway modulation to tune secretory, enterocyte, and other intestinal fates without recreating artificial spatial gradients.

• Gamithromycin: From Lung PK to Translational Strategy

  2026-08-28

  Gamithromycin, also known as ML-1709460, illustrates why respiratory anti-infective research should connect ribosomal mechanism, pulmonary distribution, intracellular exposure, and AUC24h/MIC rather than rely on plasma concentration alone. This evidence-led perspective translates foal pharmacokinetic findings into practical strategies for veterinary respiratory models while defining the limits of cross-species extrapolation.

• Carbapenemase Gene Dynamics in CREC, 2022–2024

  2026-08-27

  A 2025 BMC Microbiology study mapped carbapenemase-encoding genes in carbapenem-resistant Enterobacter cloacae collected from eight teaching hospitals in Guangdong, combining gene localization, antimicrobial susceptibility, conjugation, mobile-element analysis, and ERIC-PCR typing. Its findings identify plasmid-associated blaNDM-1 as a major transmission concern and show why resistance phenotyping should be interpreted alongside molecular surveillance.

8046 records 1/537 page Next 12345 下5页 Last page